- Liver biopsy in the differential diagnosis of cholestatic diseases in infants
Liver biopsy in the differential diagnosis of cholestatic diseases in infants
Paediatric Surgery (Ukraine). 2025. 3(88): 57-62. doi: 10.15574/PS.2025.3(88).5762
Kurylo H. V.1,2, Shchur O. V.1, Kovalyk O. Ya.2
1Danylo Halytsky Lviv National Medical University, Ukraine
2CNPE "Lviv Territorial Medical Association "Multidisciplinary Clinical Hospital of Intensive Treatment Methods and Emergency Medical Care", Ukraine
For citation: Kurylo HV, Shchur OV, Kovalyk OYa. (2025). Liver biopsy in the differential diagnosis of cholestatic diseases in infants. Paediatric Surgery (Ukraine). 3(88): 57-62. doi: 10.15574/PS.2025.3(88).5762.
Article received: Jul 05, 2025. Accepted for publication: Sep 16, 2025.
Liver biopsy (LB) is the most reliable source in the diagnosis of cholestatic liver diseases, the most informative in the prognosis of organ functioning after Kasai operation.
Aim – to establish the terms, conditions, age, and methods of LB in young children with cholestatic liver diseases to determine the differential diagnostic informativeness of histological studies.
Materials and methods. 118 children with jaundice aged 1.5-4.5 months underwent morphological examination of LB to verify the diagnosis.
Results. All LB met the standard (≥10 portal tracts). In 64 (54.2%) children histological examination revealed characteristic signs of biliary atresia (BA): characteristic features – ductal proliferation, fibrosis, inflammation, obliteration. Percutaneous LB at the age of 30 days provides diagnostic accuracy, confirmed by cholangiography and postoperative LB. Primary familial intrahepatic cholestasis (PFIC) is characterized by ductopenia, lobular infiltration, and hepatocyte necrosis. Tactics after 45-60 days of life become more complicated – laparoscopic LB with cholangiography and possible transition to Kasai operation (KO) is recommended if conditions are available.
Conclusions. LB is a key method in the differential diagnosis of neonatal cholestasis, especially when BA is suspected. In 92.1% of our patients, LB verified BA, which is consistent with the literature data. In cases of non-atresic forms of cholestasis, the morphological picture is less specific, so LB should be supplemented with genetic testing. The patient's age has a critical impact on informativeness: up to the 14th day of life – low diagnostic value, on the 30th day – the optimal period for performing LB. Conditions for effectiveness: high-quality biopsy (≥10 portal tracts), choice of the correct technique (puncture or laparoscopic), qualified morphological analysis in combination with clinical and laboratory data. These results emphasize the importance of timely and high-quality LB for determining further treatment tactics, including surgical intervention or molecular diagnostics.
The research was carried out in accordance with the principles of the Declaration of Helsinki. Informed consent of the child and child's parents was obtained for the research.
The authors declare no conflict of interest.
Keywords: newborns, jaundice, biliary atresia, chronic cholestasis, liver biopsy, Kasai operation.
REFERENCES
1. Ali KM, Zalata KR, Barakat T, Elzeiny SM. (2024, Jan). Pathologic approach to Neonatal cholestasis with a simple scoring system for biliary atresia. Virchows Arch. 484(1): 93-102. Epub 2023 Nov 27. https://doi.org/10.1007/s00428-023-03704-5; PMid:38008855 PMCid:PMC10791702
2. Antala S, Taylor SA. (2022, Aug). Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes. Clin Liver Dis. 26(3): 341-354. Epub 2022 Jun 25. https://doi.org/10.1016/j.cld.2022.03.001; PMid:35868678 PMCid:PMC9309872
3. Arsena H, Kenny Tedja A, Gunarti H et al. (2024). Diagnostic accuracy of ultrasound in cholestatic infants with biliary atresia. Turk Arch Pediatr. 59(5): 449-453. https://doi.org/10.5152/TurkArchPediatr.2024.24084; PMid:39440361 PMCid:PMC11393491
4. Brahee DD, Lampl BS. (2022, Apr). Neonatal diagnosis of biliary atresia: a practical review and update. Pediatr Radiol. 52(4): 685-692. Epub 2021 Jul 31. https://doi.org/10.1007/s00247-021-05148-y; PMid:34331566
5. El-Shabrawi M, Ghaffar TYA, Baky AA et al. (2025). Evidence-based clinical practice guideline for diagnosis of neonatal and infantile cholestasis and management of its anticipated life-threatening conditions. Egypt Liver Journal. 15: 64. https://doi.org/10.1186/s43066-025-00467-3
6. European Association for the Study of the Liver (EASL). (2024, Aug). Clinical Practice Guidelines on genetic cholestatic liver diseases. J Hepatol. 81(2): 303-325. Epub 2024 Jun 8. https://doi.org/10.1016/j.jhep.2024.04.006; PMid:38851996
7. Feldman AG, Sokol RJ. (2021, Dec 1). Neonatal Cholestasis: Updates on Diagnostics, Therapeutics, and Prevention. Neoreviews. 22(12): e819-e836. https://doi.org/10.1542/neo.22-12-e819; PMid:34850148 PMCid:PMC10103174
8. Gorbatyuk OM, Makedonsky IA, Kurilo HV. (2019). Modern strategies of the diagnostics, surgical correction and prevention of congenital anomalies in newborns. Neonatology, Surgery and Perinatal Medicine. 4 (34): 88-97. https://doi.org/10.24061/2413-4260.IX.4.34.2019.7
9. Hassan S, Hertel P. (2022, Aug). Overview of Progressive Familial Intrahepatic Cholestasis. Clin Liver Dis. 26(3): 371-390. https://doi.org/10.1016/j.cld.2022.03.003; PMid:35868680
10. Kelley-Quon LI, Shue E, Burke RV, Smith C, Kling K, Mahdi E et al. (2022, Feb). The need for early Kasai portoenterostomy: a Western Pediatric Surgery Research Consortium study. Pediatr Surg Int. 38(2): 193-199. Epub 2021 Dec 2. https://doi.org/10.1007/s00383-021-05047-1; PMid:34854975 PMCid:PMC8742784
11. Kurylo HV. (2024). Alagille syndrome in the clinical practice of a paediatric surgeon. Paediatric Surgery (Ukraine). 2(83): 49-56. https://doi.org/10.15574/PS.2024.83.49
12. Kurylo HV. (2024). Biliary atresia: the path to diagnosis. Paediatric Surgery (Ukraine). 4(85): 16-21. https://doi.org/10.15574/PS.2024.4(85).1621
13. Kurylo HV. (2024). Byler's disease: conservative and surgical treatment strategies. Paediatric Surgery (Ukraine). 3(84): 117-123. https://doi.org/10.15574/PS.2024.3(84).117123
14. Kurylo HV. (2025). Liver transplantation in children: pre-transplantation preparation tactics. Paediatric Surgery (Ukraine). 1(86): 40-44. https://doi.org/10.15574/PS.2025.1(86).4044
15. Kurylo HV. (2025). Transplant surgeon's strategies in cases of cholestatic jaundice in children of the first months of life. Modern Pediatrics. Ukraine. 3(147): 60-66. https://doi.org/10.15574/SP.2025.3(147).6066
16. Lendahl U, Lui VCH, Chung PHY, Tam PKH. (2021, Dec). Biliary Atresia – emerging diagnostic and therapy opportunities. EBioMedicine. 74: 103689. Epub 2021 Nov 12. https://doi.org/10.1016/j.ebiom.2021.103689; PMid:34781099 PMCid:PMC8604670
17. Nguyen AP, Pham YHT, Vu GH, Nguyen MH, Hoang TN, Holterman A. (2021, Jul). Biliary atresia liver histopathological determinants of early post-Kasai outcome. J Pediatr Surg. 56(7): 1169-1173. Epub 2021 Mar 26. https://doi.org/10.1016/j.jpedsurg.2021.03.039; PMid:33838902
18. Russi AE, Pandurangi S, Bezerra JA. (2022, Jan 28). The Liver Biopsy in Neonatal Cholestasis: Just a Cherry on Top? Clin Liver Dis (Hoboken). 19(3): 111-113. https://doi.org/10.1002/cld.1190; PMid:35355844 PMCid:PMC8958248
19. Srivastava A. (2014, Mar). Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 4(1): 25-36. https://doi.org/10.1016/j.jceh.2013.10.005; PMid:25755532 PMCid:PMC4017198
20. Tam PKH, Wells RG, Tang CSM, Lui VCH, Hukkinen M, Luque CD et al. (2024, Jul 11). Biliary atresia. Nat Rev Dis Primers. 10(1): 47. https://doi.org/10.1038/s41572-024-00533-x; PMid:38992031 PMCid:PMC11956545
